TransMedics Group's revenue per share for the
three
months ended in Mar. 2024 was $2.79.
TransMedics Group's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was $8.93.
During the past 12 months, the average Revenue Per Share Growth Rate of TransMedics Group was 131.90% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 92.70% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 49.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for TransMedics Group's Revenue per Share or its related term are showing as below:
TMDX'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 17.5 Med: 25 Max: 92.7
Current: 92.7
During the past 8 years, TransMedics Group's highest 3-Year average Revenue Per Share Growth Rate was 92.70% per year. The lowest was 17.50% per year. And the median was 25.00% per year.
TMDX's 3-Year Revenue Growth Rate is ranked better than 96.66% of 748
companies
in the Medical Devices & Instruments industry
Industry Median: 7
vs TMDX: 92.70
TransMedics Group Revenue per Share Historical Data
The historical data trend for TransMedics Group's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TransMedics Group's Revenue per Share
For the Medical Devices subindustry, TransMedics Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where TransMedics Group's PS Ratio falls into.
TransMedics Group Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
TransMedics Group's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (NAS:TMDX) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
TransMedics Group Revenue per Share Related Terms
Thank you for viewing the detailed overview of TransMedics Group's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your 